Coronavirus Notebook: Nobel Laureates Press Germany To Back Vaccine IP Waiver

 
• By Ian Schofield

The EU vaunts its vaccine donations and starts building resilience against future health threats, and the UK MHRA says Moderna can be used as a booster dose. Aviptadil has received scientific advice from the MHRA for its potential use as a treatment for COVID-19 patients.

Businessman holding a foldable smartphone with INTELLECTUAL PROPERTY inscription
Pharma firms say IP is essential for innovative R&D on new vaccines • Source: Alamy

More from Europe

More from Geography